Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Impact of Tiotropium Add-on Therapy in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Tiotropium Respimat®;   Drug: Inhaled Corticosteroid/Long-acting beta-agonist Sponsor:   Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

A Study on Whether Patients Prefer the Spiriva ® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium Respimat® (T1);   Drug: Tiotropium Handihaler® (T2) Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Spiolto ® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist;   Drug: Tripple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2019 Category: Research Source Type: clinical trials

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
Condition:   Chronic Obstructive Pulmonary Disease (COPD) Intervention:   Drug: Tiotropium Sponsor:   Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2019 Category: Research Source Type: clinical trials

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
Condition:   Chronic Obstructive Pulmonary Disease (COPD) Intervention:   Drug: Tiotropium Sponsor:   Orion Corporation, Orion Pharma Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2019 Category: Research Source Type: clinical trials

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
Condition:   Chronic Obstructive Pulmonary Disease (COPD) Intervention:   Drug: Tiotropium Sponsor:   Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2019 Category: Research Source Type: clinical trials

Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
Condition:   COPD Interventions:   Drug: Ensifentrine (formerly RPL554) 0.375 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) 0.75 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) 1.5 mg twice daily plus placebo, in addition to tiotropi um;   Drug: Ensifentrine (formerly RPL554) 3.0 mg twice daily plus placebo, in addition to tiotropium;   Drug: Ensifentrine (formerly RPL554) placebo twice daily, in addition to tiotropium Sponsors:   Verona Pharma plc;   IQVIA;   LGC Limit...
Source: ClinicalTrials.gov - May 3, 2019 Category: Research Source Type: clinical trials